SNANF
Price
$0.41
Change
+$0.05 (+13.89%)
Updated
Aug 15 closing price
Capitalization
45M
TDVXF
Price
$13.35
Change
+$0.35 (+2.69%)
Updated
Aug 13 closing price
Capitalization
1.36B
Interact to see
Advertisement

SNANF vs TDVXF

Header iconSNANF vs TDVXF Comparison
Open Charts SNANF vs TDVXFBanner chart's image
Sona Nanotech
Price$0.41
Change+$0.05 (+13.89%)
Volume$7.5K
Capitalization45M
DYNAVOX GROUP AB
Price$13.35
Change+$0.35 (+2.69%)
Volume$500
Capitalization1.36B
SNANF vs TDVXF Comparison Chart in %
Loading...
SNANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TDVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNANF vs. TDVXF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNANF is a Hold and TDVXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (SNANF: $0.41 vs. TDVXF: $13.35)
Brand notoriety: SNANF and TDVXF are both not notable
SNANF represents the Medical Specialties, while TDVXF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SNANF: 68% vs. TDVXF: 30%
Market capitalization -- SNANF: $45M vs. TDVXF: $1.36B
SNANF [@Medical Specialties] is valued at $45M. TDVXF’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.48B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNANF’s FA Score shows that 0 FA rating(s) are green whileTDVXF’s FA Score has 2 green FA rating(s).

  • SNANF’s FA Score: 0 green, 5 red.
  • TDVXF’s FA Score: 2 green, 3 red.
According to our system of comparison, TDVXF is a better buy in the long-term than SNANF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNANF’s TA Score shows that 4 TA indicator(s) are bullish while TDVXF’s TA Score has 3 bullish TA indicator(s).

  • SNANF’s TA Score: 4 bullish, 6 bearish.
  • TDVXF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both SNANF and TDVXF are a bad buy in the short-term.

Price Growth

SNANF (@Medical Specialties) experienced а +7.64% price change this week, while TDVXF (@Pharmaceuticals: Other) price change was -1.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.75%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +1.62%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Industries' Descriptions

@Medical Specialties (+3.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TDVXF($1.36B) has a higher market cap than SNANF($45M). TDVXF YTD gains are higher at: 147.222 vs. SNANF (124.658). TDVXF has higher annual earnings (EBITDA): 444M vs. SNANF (-2.18M). TDVXF has more cash in the bank: 157M vs. SNANF (731K). SNANF has less debt than TDVXF: SNANF (422K) vs TDVXF (1.01B). TDVXF has higher revenues than SNANF: TDVXF (2.25B) vs SNANF (0).
SNANFTDVXFSNANF / TDVXF
Capitalization45M1.36B3%
EBITDA-2.18M444M-0%
Gain YTD124.658147.22285%
P/E RatioN/A89.71-
Revenue02.25B-
Total Cash731K157M0%
Total Debt422K1.01B0%
FUNDAMENTALS RATINGS
SNANF: Fundamental Ratings
SNANF
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNANFTDVXF
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
SNANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TDVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGLJX16.170.05
+0.31%
MFS Global Real Estate R1
REMYX19.370.03
+0.16%
Russell Inv Emerging Markets Y
CFVLX33.91N/A
N/A
Commerce Value
HGITX58.42N/A
N/A
Hartford Core Equity R5
MMNLX9.68N/A
N/A
MassMutual Small Company Val Y

SNANF and

Correlation & Price change

A.I.dvisor tells us that SNANF and TDVXF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNANF and TDVXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNANF
1D Price
Change %
SNANF100%
+12.73%
TDVXF - SNANF
24%
Poorly correlated
N/A
SNNUF - SNANF
8%
Poorly correlated
N/A
SSMXY - SNANF
3%
Poorly correlated
+1.04%
SMMNY - SNANF
1%
Poorly correlated
+0.81%
TCHBF - SNANF
0%
Poorly correlated
N/A
More

TDVXF and

Correlation & Price change

A.I.dvisor tells us that TDVXF and SNANF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TDVXF and SNANF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TDVXF
1D Price
Change %
TDVXF100%
N/A
SNANF - TDVXF
23%
Poorly correlated
+12.73%
XAIR - TDVXF
23%
Poorly correlated
N/A
AHICF - TDVXF
21%
Poorly correlated
N/A
PHCCF - TDVXF
18%
Poorly correlated
N/A
STSS - TDVXF
7%
Poorly correlated
-2.93%
More